I highly disagree with the proposed restrictions regarding "complex" products, which isn't well-defined in the notice write-up. Not only would creating additional barriers and limiting opportunity to retail would have broader implications and negative outcomes for capital markets overall, but it removes the necessary risk management tools in an increasingly complex and evolving
I strongly oppose restrictions on my right to invest in public investments such as leveraged and inverse funds. I use these funds as a hedge to help diversify and protect my other investments. Im concerned that government intervention in these financial instruments will destroy their ability to provide safety and protection to my investment portfolio.
Investing can be very dangerous. Investing
I understand the financial risk that I am taking when I purchase leveraged and inverse funds. They are important aspects of my investing strategy. Please do not restrict these assets from the marketplace. Every ETF has a place in the market. Thank you.
Please do not restrict access to geared financial products. They are a beneficial part of an overall portfolio strategy. When accounting for time horizon, percentage of portfolio, hedging, and proper asset allocation geared products fit an important need of investors.
Losing the ability to invest in leveraged funds would put me at a financial disadvantage. It would disrupt long-term investment strategies I've already undertaken. I understand the risks and only use them as a limited part of my overall assets.
Individual investors should have the right to invest in a variety of asset classes and financial securities with varying amounts of risk rather than restrict them to a privileged few (trusts, hedge funds, high net worth individuals, etc.).
Summary
Due to the recent outbreak of coronavirus disease (COVID-19), FINRA reminds member firms to consider pandemic-related business continuity planning, including whether their business continuity plans (BCPs) are sufficiently flexible to address a wide range of possible effects in the event of a pandemic in the United States. Each member firm is also encouraged to review its BCP to consider
/**/
Publication Date: March 31, 2025Interpretations are marked in blue background beneath the rule text to which they relate.17a-5 Reports to be made by certain brokers and dealers.This section applies to the following types of entities: Except as provided in this introductory text, a broker or dealer, including an OTC derivatives dealer as that term is defined in § 240.3b-12 registered
I am an active individual investor who uses leveraged and inverse ETFs as a component of a diversified portfolio, and I vehemently oppose restrictions or other qualification requirements for individual investors trading in publicly traded inverse and leveraged ETFs. I am fully capable of reading the prospectuses and evaluating the risks on my own as well as determining the strategy to implement
This letter is to oppose each and every one of the extensive restrictions being contemplated in Regulatory Notice 22-08. The proposed rule should be revoked. It is the latest open attack on the common man’s access to the new class of leveraged products, and in so doing, it is illegal.
The original attack came from the SEC in late 2019. That proposed rule, File No. S7-24-15, which limited
